These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1166 related articles for article (PubMed ID: 31342055)

  • 1. Early imaging predictors of long-term outcomes in relapse-onset multiple sclerosis.
    Brownlee WJ; Altmann DR; Prados F; Miszkiel KA; Eshaghi A; Gandini Wheeler-Kingshott CAM; Barkhof F; Ciccarelli O
    Brain; 2019 Aug; 142(8):2276-2287. PubMed ID: 31342055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spatial distribution of multiple sclerosis lesions in the cervical spinal cord.
    Eden D; Gros C; Badji A; Dupont SM; De Leener B; Maranzano J; Zhuoquiong R; Liu Y; Granberg T; Ouellette R; Stawiarz L; Hillert J; Talbott J; Bannier E; Kerbrat A; Edan G; Labauge P; Callot V; Pelletier J; Audoin B; Rasoanandrianina H; Brisset JC; Valsasina P; Rocca MA; Filippi M; Bakshi R; Tauhid S; Prados F; Yiannakas M; Kearney H; Ciccarelli O; Smith SA; Andrada Treaba C; Mainero C; Lefeuvre J; Reich DS; Nair G; Shepherd TM; Charlson E; Tachibana Y; Hori M; Kamiya K; Chougar L; Narayanan S; Cohen-Adad J
    Brain; 2019 Mar; 142(3):633-646. PubMed ID: 30715195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis.
    Fisniku LK; Brex PA; Altmann DR; Miszkiel KA; Benton CE; Lanyon R; Thompson AJ; Miller DH
    Brain; 2008 Mar; 131(Pt 3):808-17. PubMed ID: 18234696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple sclerosis lesions in motor tracts from brain to cervical cord: spatial distribution and correlation with disability.
    Kerbrat A; Gros C; Badji A; Bannier E; Galassi F; Combès B; Chouteau R; Labauge P; Ayrignac X; Carra-Dalliere C; Maranzano J; Granberg T; Ouellette R; Stawiarz L; Hillert J; Talbott J; Tachibana Y; Hori M; Kamiya K; Chougar L; Lefeuvre J; Reich DS; Nair G; Valsasina P; Rocca MA; Filippi M; Chu R; Bakshi R; Callot V; Pelletier J; Audoin B; Maarouf A; Collongues N; De Seze J; Edan G; Cohen-Adad J
    Brain; 2020 Jul; 143(7):2089-2105. PubMed ID: 32572488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain and cord myelin water imaging: a progressive multiple sclerosis biomarker.
    Kolind S; Seddigh A; Combes A; Russell-Schulz B; Tam R; Yogendrakumar V; Deoni S; Sibtain NA; Traboulsee A; Williams SC; Barker GJ; Brex PA
    Neuroimage Clin; 2015; 9():574-80. PubMed ID: 26594633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spinal cord lesions and brain grey matter atrophy independently predict clinical worsening in definite multiple sclerosis: a 5-year, multicentre study.
    Rocca MA; Valsasina P; Meani A; Gobbi C; Zecca C; Barkhof F; Schoonheim MM; Strijbis EM; Vrenken H; Gallo A; Bisecco A; Ciccarelli O; Yiannakas M; Rovira A; Sastre-Garriga J; Palace J; Matthews L; Gass A; Eisele P; Lukas C; Bellenberg B; Margoni M; Preziosa P; Filippi M;
    J Neurol Neurosurg Psychiatry; 2023 Jan; 94(1):10-18. PubMed ID: 36171105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of asymptomatic spinal cord lesions and atrophy with disability 5 years after a clinically isolated syndrome.
    Brownlee WJ; Altmann DR; Alves Da Mota P; Swanton JK; Miszkiel KA; Wheeler-Kingshott CG; Ciccarelli O; Miller DH
    Mult Scler; 2017 Apr; 23(5):665-674. PubMed ID: 27481210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain microstructural and metabolic alterations detected in vivo at onset of the first demyelinating event.
    Collorone S; Prados F; Kanber B; Cawley NM; Tur C; Grussu F; Solanky BS; Yiannakas M; Davagnanam I; Wheeler-Kingshott CAMG; Barkhof F; Ciccarelli O; Toosy AT
    Brain; 2021 Jun; 144(5):1409-1421. PubMed ID: 33903905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cortical grey matter sodium accumulation is associated with disability and secondary progressive disease course in relapse-onset multiple sclerosis.
    Brownlee WJ; Solanky B; Prados F; Yiannakas M; Da Mota P; Riemer F; Cardoso MJ; Ourselin S; Golay X; Gandini Wheeler-Kingshott C; Ciccarelli O
    J Neurol Neurosurg Psychiatry; 2019 Jul; 90(7):755-760. PubMed ID: 30948625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spinal cord lesions: A modest contributor to diagnosis in clinically isolated syndromes but a relevant prognostic factor.
    Arrambide G; Rovira A; Sastre-Garriga J; Tur C; Castilló J; Río J; Vidal-Jordana A; Galán I; Rodríguez-Acevedo B; Midaglia L; Nos C; Mulero P; Arévalo MJ; Comabella M; Huerga E; Auger C; Montalban X; Tintore M
    Mult Scler; 2018 Mar; 24(3):301-312. PubMed ID: 28301287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early Predictors of 9-Year Disability in Pediatric Multiple Sclerosis.
    De Meo E; Bonacchi R; Moiola L; Colombo B; Sangalli F; Zanetta C; Amato MP; Martinelli V; Rocca MA; Filippi M
    Ann Neurol; 2021 May; 89(5):1011-1022. PubMed ID: 33598931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cortical involvement determines impairment 30 years after a clinically isolated syndrome.
    Haider L; Prados F; Chung K; Goodkin O; Kanber B; Sudre C; Yiannakas M; Samson RS; Mangesius S; Thompson AJ; Gandini Wheeler-Kingshott CAM; Ciccarelli O; Chard DT; Barkhof F
    Brain; 2021 Jun; 144(5):1384-1395. PubMed ID: 33880511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum neurofilament as a predictor of disease worsening and brain and spinal cord atrophy in multiple sclerosis.
    Barro C; Benkert P; Disanto G; Tsagkas C; Amann M; Naegelin Y; Leppert D; Gobbi C; Granziera C; Yaldizli Ö; Michalak Z; Wuerfel J; Kappos L; Parmar K; Kuhle J
    Brain; 2018 Aug; 141(8):2382-2391. PubMed ID: 29860296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Grey matter involvement by focal cervical spinal cord lesions is associated with progressive multiple sclerosis.
    Kearney H; Miszkiel KA; Yiannakas MC; Altmann DR; Ciccarelli O; Miller DH
    Mult Scler; 2016 Jun; 22(7):910-20. PubMed ID: 26432854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain and spinal cord abnormalities in multiple sclerosis. Correlation between MRI parameters, clinical subtypes and symptoms.
    Nijeholt GJ; van Walderveen MA; Castelijns JA; van Waesberghe JH; Polman C; Scheltens P; Rosier PF; Jongen PJ; Barkhof F
    Brain; 1998 Apr; 121 ( Pt 4)():687-97. PubMed ID: 9577394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spinal cord grey matter abnormalities are associated with secondary progression and physical disability in multiple sclerosis.
    Kearney H; Schneider T; Yiannakas MC; Altmann DR; Wheeler-Kingshott CA; Ciccarelli O; Miller DH
    J Neurol Neurosurg Psychiatry; 2015 Jun; 86(6):608-14. PubMed ID: 25097217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three dimensional MRI estimates of brain and spinal cord atrophy in multiple sclerosis.
    Liu C; Edwards S; Gong Q; Roberts N; Blumhardt LD
    J Neurol Neurosurg Psychiatry; 1999 Mar; 66(3):323-30. PubMed ID: 10084530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Asymptomatic spinal cord lesions do not predict the time to disability in patients with early multiple sclerosis.
    Dekker I; Sombekke MH; Witte BI; Geurts JJ; Barkhof F; Uitdehaag BM; Killestein J; Wattjes MP
    Mult Scler; 2018 Apr; 24(4):481-490. PubMed ID: 29106327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitoxantrone: a review of its use in multiple sclerosis.
    Scott LJ; Figgitt DP
    CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conversion of clinically isolated syndrome to multiple sclerosis: a prospective study.
    Kolčava J; Kočica J; Hulová M; Dušek L; Horáková M; Keřkovský M; Stulík J; Dostál M; Kuhn M; Vlčková E; Bednařík J; Benešová Y
    Mult Scler Relat Disord; 2020 Sep; 44():102262. PubMed ID: 32570179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 59.